Heart Attack Study Ties Xience and Taxus Liberte

Researchers who conducted a recent study of heart attack victims found a tie between the efficiency of Abbott's Xience stent and Boston Scientific's Taxus Liberte over six months. Presented this past weekend, the results revealed that out of 335 heart attack victims, 3.2% who had the Xience stent died within a month versus 1.3% of those who were given the Taxus Liberte and died within the same time period.